Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06276881 · ClinicalTrials.gov registry record · NA

Visual Stimulation for Pain Relief

A NA study of Pain, sponsored by Dandelion Science.

Completed
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT06276881: Completed NA study of Pain, sponsored by Dandelion Science.

NCT06276881 is a NA study of Pain that has completed, run by Dandelion Science. The registered enrollment target is 75 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06276881, a NA study of Pain, has completed, sponsored by Dandelion Science.

COMPLETED
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to investigate a novel neuromodulatory approach utilizing visual stimulation to impact pain perception in healthy participants.

Primary Outcome

Standard computerized scale of perceived pain level. The scale ranges from 0 to 100, a score of "0" indicating "No Pain" and a score of "100" indicating "Most Pain". Higher score indicates a worse outcome as perceived pain is increasing, lower score indicates a better outcome as perceived pain is decreasing.

Conditions Studied

Interventions

  • BEHAVIORAL Visual Stimulation

Study Locations (1)

New Jersey

  • Dandelion Science - Hoboken

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2022-06-03
Est. Completion 2023-05-01
Phase NA
Dandelion Science

1 total trials

What the finished NCT06276881 record still lists

NCT06276881 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (75% lower).

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 1 intervention - of which Visual Stimulation is the first listed.

NCT06276881 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT06276881 about?

NCT06276881 is a clinical study titled "Visual Stimulation for Pain Relief". The goal of this study is to investigate a novel neuromodulatory approach utilizing visual stimulation to impact pain perception in healthy participants.

What is the current status of trial NCT06276881?

This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2022-06-03. Estimated completion is 2023-05-01.

What conditions does trial NCT06276881 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT06276881?

The interventions under investigation include: Visual Stimulation (BEHAVIORAL).

Who is sponsoring clinical trial NCT06276881?

This trial is sponsored by Dandelion Science, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06276881 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06276881's enrollment target sits among peer trials

75 208th of 374 higher than 166 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06276881, the US trial registry maintained by the National Library of Medicine. NCT06276881 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.